Logo image of CWD

CALIBERCOS INC-CL A (CWD) Stock Fundamental Analysis

NASDAQ:CWD - Nasdaq - US13000T1097 - Common Stock - Currency: USD

2.92  +0.01 (+0.34%)

After market: 2.91 -0.01 (-0.34%)

Fundamental Rating

1

Overall CWD gets a fundamental rating of 1 out of 10. We evaluated CWD against 235 industry peers in the Capital Markets industry. CWD has a bad profitability rating. Also its financial health evaluation is rather negative. CWD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CWD had negative earnings in the past year.
CWD had a positive operating cash flow in the past year.
CWD had negative earnings in 4 of the past 5 years.
CWD had negative operating cash flow in 4 of the past 5 years.
CWD Yearly Net Income VS EBIT VS OCF VS FCFCWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

With a Return On Assets value of -19.58%, CWD is not doing good in the industry: 88.94% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -19.58%
ROE N/A
ROIC N/A
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWD Yearly ROA, ROE, ROICCWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

CWD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWD Yearly Profit, Operating, Gross MarginsCWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for CWD has been increased compared to 1 year ago.
CWD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CWD has a worse debt to assets ratio.
CWD Yearly Shares OutstandingCWD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CWD Yearly Total Debt VS Total AssetsCWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

CWD has an Altman-Z score of -1.14. This is a bad value and indicates that CWD is not financially healthy and even has some risk of bankruptcy.
CWD has a Altman-Z score of -1.14. This is amonst the worse of the industry: CWD underperforms 89.36% of its industry peers.
The Debt to FCF ratio of CWD is 241.61, which is on the high side as it means it would take CWD, 241.61 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 241.61, CWD is not doing good in the industry: 60.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 241.61
Altman-Z -1.14
ROIC/WACCN/A
WACCN/A
CWD Yearly LT Debt VS Equity VS FCFCWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

CWD has a Current Ratio of 0.42. This is a bad value and indicates that CWD is not financially healthy enough and could expect problems in meeting its short term obligations.
CWD has a worse Current ratio (0.42) than 80.00% of its industry peers.
CWD has a Quick Ratio of 0.42. This is a bad value and indicates that CWD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.41, CWD is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.41
CWD Yearly Current Assets VS Current LiabilitesCWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CWD have decreased strongly by -23.23% in the last year.
CWD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.01%.
CWD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.07% yearly.
EPS 1Y (TTM)-23.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.01%
Revenue 1Y (TTM)-58.01%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-68.36%

3.2 Future

CWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.41% yearly.
The Revenue is expected to grow by 10.57% on average over the next years. This is quite good.
EPS Next Y78.62%
EPS Next 2Y42.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.77%
Revenue Next 2Y10.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CWD Yearly Revenue VS EstimatesCWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
CWD Yearly EPS VS EstimatesCWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 -5 -10 -15

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 5.78, which indicates a rather cheap valuation of CWD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CWD indicates a rather cheap valuation: CWD is cheaper than 95.74% of the companies listed in the same industry.
CWD is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 5.78
CWD Price Earnings VS Forward Price EarningsCWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CWD indicates a somewhat cheap valuation: CWD is cheaper than 74.04% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.2
EV/EBITDA N/A
CWD Per share dataCWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CWD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CWD's earnings are expected to grow with 42.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.41%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CWD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALIBERCOS INC-CL A

NASDAQ:CWD (7/21/2025, 8:00:01 PM)

After market: 2.91 -0.01 (-0.34%)

2.92

+0.01 (+0.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)N/A N/A
Inst Owners4.69%
Inst Owner Change-7.7%
Ins Owners27.66%
Ins Owner Change-0.23%
Market Cap3.85M
Analysts80
Price Target38.76 (1227.4%)
Short Float %1.39%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.84%
Min Revenue beat(2)3.12%
Max Revenue beat(2)28.56%
Revenue beat(4)4
Avg Revenue beat(4)33.03%
Min Revenue beat(4)3.12%
Max Revenue beat(4)80.63%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)913.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4600%
EPS NY rev (1m)0%
EPS NY rev (3m)-6450%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-27.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.78
P/S 0.11
P/FCF 11.2
P/OCF 11.2
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-18
EYN/A
EPS(NY)0.51
Fwd EY17.29%
FCF(TTM)0.26
FCFY8.92%
OCF(TTM)0.26
OCFY8.92%
SpS26.84
BVpS-11.98
TBVpS-11.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.58%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 0.97%
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 241.61
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.41
Altman-Z -1.14
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.01%
EPS Next Y78.62%
EPS Next 2Y42.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-58.01%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-68.36%
Revenue Next Year-6.77%
Revenue Next 2Y10.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y65.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.19%
FCF growth 3YN/A
FCF growth 5Y-35.8%
OCF growth 1Y103.19%
OCF growth 3YN/A
OCF growth 5Y-35.8%